Product Description
- Four - to eight - fold more active than erythromycin against H. influenzae 1
- Concentrates within phagocytes and released at infection site -
10 - to 100 - fold higher tissue concentrations than in serum 1
- Effective for up to 4 days after a dose - shorter course of therapy
- During :
. URTI - Tonsillitis , Sinusitis
. LRTI - Pharyngitis, Bronchitis, Pneumonia
. Urogenital infections - Vaginitis, Gonorrhoea
. SSTI - Acne Vulgaris and Skin infections